EY Acquires Aqurance to Boost Lifesciences Transformation on Veeva
The acquisition of Aqurance aims to strengthen the EY organisation’s Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.
Societe Anonyme | 15/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy